Table 3.
Demographic and clinical characteristics of patients with Ebola virus disease associated uveitis
| Patient specific characteristics | |
| Number of patients | 21 |
| Median age at diagnosis of uveitis (IQR) | 36 (28–42) |
| Average number of days in ETU (IQR) | 17 (12.5–21.5) |
| Gender, % male | 38 |
| Race (Liberian,%) | 100 |
| Bilateral uveitis, (%) | 5 (23.8) |
| Anterior uveitis, (%) | 3 (14.3) |
| Intermediate uveitis, (%) | 0 |
| Posterior uveitis, (%) | 12 (57.1) |
| Panuveitis, (%) | 6 (28.6) |
| Anatomic form of uveitis | |
| Number of eyes affected | 26 |
| Anterior uveitis, (%) | 4 (15.4) |
| Intermediate uveitis, (%) | 0 |
| Posterior uveitis, (%) | 15 (57.7) |
| Panuveitis, (%) | 7 (26.9) |
| Ocular findings | Number (%) |
| Corneal edema | 2 (7.7) |
| Keratic precipitates | 5 (19.2) |
| Anterior segment cell | 4 (15.4) |
| Posterior synechiae | 11 (42.3) |
| Vitritis | 5 (19.2) |
| Cataract | 1 (3.8) |
| Chorioretinal scar | 16 (61.5) |
| Phthisis Bulbi | 1 (3.8) |
| Afferent pupillary defect | 4 (15.4) |
| Ocular hypertension | 2 (7.7) |
| Exotropia | 2 (7.7) |
|
World Health Organization Classification of Vision Impairment |
Number of eyes (Percentage of total eyes) |
| Normal/mild visual impairment (better than 20/70) |
14 (53.8) |
| Moderate visual impairment (20/70–20/200) | 2 (7.7) |
| Severe visual impairment (20/200–20/400) | 0 |
| Blindness (worse than 20/400) | 10 (38.5) |